Johnson & Johnson (JNJ) Long-Term Debt Issuances (2009 - 2025)
Johnson & Johnson recorded quarterly Long-Term Debt Issuances of $9.1 billion in Q1 2025, up 913700.0% quarter-over-quarter from $1.0 million in Q3 2024, and up 456800.0% year-over-year from N/an in Q1 2024.
Johnson & Johnson's Long-Term Debt Issuances history runs 15 years deep, the most recent figure standing at $9.1 billion for Q1 2025.
- In Q1 2025, Long-Term Debt Issuances rose 456800.0% year-over-year to $9.1 billion; the TTM figure through Dec 2025 stood at $9.1 billion (up 37.21% YoY), while the FY2025 annual figure was $9.1 billion, up 37.21% from the prior year.
- Long-Term Debt Issuances came in at $9.1 billion for Q1 2025 at Johnson & Johnson, up from $1.0 million in the prior quarter.
- In the past five years, Long-Term Debt Issuances ranged from a high of $9.1 billion in Q1 2025 to a low of -$7.7 billion in Q4 2023.
- A 4-year average of $1.8 billion and a median of $2.0 million in 2021 frame the typical range for Long-Term Debt Issuances.
- Across the five-year window, Long-Term Debt Issuances slumped 99.97% in 2024 and jumped 456800.0% in 2025, its largest moves.
- Johnson & Johnson's Long-Term Debt Issuances stood at $2.0 million in 2021, then slumped by 383800.0% to -$7.7 billion in 2023, then jumped by 100.01% to $1.0 million in 2024, then soared by 913700.0% to $9.1 billion in 2025.
- According to Business Quant data, Long-Term Debt Issuances over the past three periods registered $9.1 billion, $1.0 million, and $6.7 billion for Q1 2025, Q3 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | - |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 7.99 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | - |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 3.96 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | - |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | - |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2025 | 9.14 Bn |
| Mar 30, 2025 | 9.14 Bn |
| Sep 29, 2024 | 1.00 Mn |
| Sep 29, 2024 | 1.00 Mn |
| Jun 30, 2024 | 6.66 Bn |
| Jun 30, 2024 | 6.66 Bn |
| Mar 31, 2024 | 2.00 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Oct 1, 2023 | -7.67 Bn |
| Oct 1, 2023 | -7.67 Bn |
| Apr 2, 2023 | 7.67 Bn |
| Apr 2, 2023 | 7.67 Bn |
| Jan 1, 2023 | -1.00 Mn |
| Jan 1, 2023 | -1.00 Mn |
| Oct 3, 2021 | 2.00 Mn |
| Oct 3, 2021 | 2.00 Mn |
| Apr 4, 2021 | 1.00 Mn |
| Apr 4, 2021 | 1.00 Mn |
| Sep 27, 2020 | 7.43 Bn |
| Sep 27, 2020 | 7.43 Bn |
| Jun 28, 2020 | 1.00 Mn |
| Jun 28, 2020 | 1.00 Mn |
| Dec 29, 2019 | 2.00 Mn |
| Dec 29, 2019 | 2.00 Mn |
| Jun 30, 2019 | 1.00 Mn |
| Jun 30, 2019 | 1.00 Mn |
| Dec 30, 2018 | -1.00 Mn |
| Dec 30, 2018 | -1.00 Mn |
| Sep 30, 2018 | 3.00 Mn |
| Sep 30, 2018 | 3.00 Mn |
| Jul 1, 2018 | 1.00 Mn |
| Jul 1, 2018 | 1.00 Mn |
| Apr 1, 2018 | 2.00 Mn |
| Apr 1, 2018 | 2.00 Mn |
| Dec 31, 2017 | 4.53 Bn |
| Dec 31, 2017 | 4.53 Bn |
| Oct 1, 2017 | 1.00 Mn |
| Oct 1, 2017 | 1.00 Mn |
| Apr 2, 2017 | 4.46 Bn |
| Apr 2, 2017 | 4.46 Bn |
| Jan 1, 2017 | 12.00 Bn |
| Jan 1, 2017 | 12.00 Bn |
| Apr 3, 2016 | 7.44 Bn |
| Apr 3, 2016 | 7.44 Bn |
| Mar 29, 2015 | 3.00 Mn |
| Mar 29, 2015 | 3.00 Mn |
| Dec 28, 2014 | 2.00 Bn |
| Dec 28, 2014 | 2.00 Bn |
| Sep 28, 2014 | 4.00 Mn |
| Sep 28, 2014 | 4.00 Mn |
| Jun 29, 2014 | -3.00 Mn |
| Jun 29, 2014 | -3.00 Mn |
| Mar 30, 2014 | 16.00 Mn |
| Mar 30, 2014 | 16.00 Mn |
| Dec 29, 2013 | 3.56 Bn |
| Dec 29, 2013 | 3.56 Bn |
| Sep 29, 2013 | 45.00 Mn |
| Sep 29, 2013 | 45.00 Mn |
| Mar 31, 2013 | 6.00 Mn |
| Mar 31, 2013 | 6.00 Mn |
| Dec 30, 2012 | 29.00 Mn |
| Dec 30, 2012 | 29.00 Mn |
| Sep 30, 2012 | 10.00 Mn |
| Sep 30, 2012 | 10.00 Mn |
| Jul 1, 2012 | 4.00 Mn |
| Jul 1, 2012 | 4.00 Mn |
| Apr 1, 2012 | 2.00 Mn |
| Apr 1, 2012 | 2.00 Mn |
| Jan 1, 2012 | 3.39 Bn |
| Jan 1, 2012 | 3.39 Bn |
| Apr 3, 2011 | 8.00 Mn |
| Apr 3, 2011 | 8.00 Mn |
| Jun 28, 2009 | 7.00 Mn |
| Jun 28, 2009 | 7.00 Mn |
| Mar 29, 2009 | 2.00 Mn |
| Mar 29, 2009 | 2.00 Mn |